IN2012DN02709A - - Google Patents

Download PDF

Info

Publication number
IN2012DN02709A
IN2012DN02709A IN2709DEN2012A IN2012DN02709A IN 2012DN02709 A IN2012DN02709 A IN 2012DN02709A IN 2709DEN2012 A IN2709DEN2012 A IN 2709DEN2012A IN 2012DN02709 A IN2012DN02709 A IN 2012DN02709A
Authority
IN
India
Prior art keywords
foams
hydroxy acid
aloe vera
humectant
propellant
Prior art date
Application number
Other languages
English (en)
Inventor
Zorko Abram Albert
Goldstein Iulian
Original Assignee
Stieffl Res Australia Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=43825425&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IN2012DN02709(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Stieffl Res Australia Pty Ltd filed Critical Stieffl Res Australia Pty Ltd
Publication of IN2012DN02709A publication Critical patent/IN2012DN02709A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/886—Aloeaceae (Aloe family), e.g. aloe vera
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/46—Ingredients of undetermined constitution or reaction products thereof, e.g. skin, bone, milk, cotton fibre, eggshell, oxgall or plant extracts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04—Dispersions; Emulsions
    • A61K8/046—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/39—Derivatives containing from 2 to 10 oxyalkylene groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
    • A61K8/86—Polyethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9794—Liliopsida [monocotyledons]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/40—Cyclodextrins; Derivatives thereof
IN2709DEN2012 2009-09-30 2010-09-28 IN2012DN02709A (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US24707309P 2009-09-30 2009-09-30
PCT/AU2010/001269 WO2011038446A1 (fr) 2009-09-30 2010-09-28 Mousse cosmétique

Publications (1)

Publication Number Publication Date
IN2012DN02709A true IN2012DN02709A (fr) 2015-09-11

Family

ID=43825425

Family Applications (1)

Application Number Title Priority Date Filing Date
IN2709DEN2012 IN2012DN02709A (fr) 2009-09-30 2010-09-28

Country Status (16)

Country Link
US (1) US20130108557A1 (fr)
EP (1) EP2482800A4 (fr)
JP (2) JP2013505967A (fr)
KR (1) KR20120081109A (fr)
CN (1) CN102711732B (fr)
AU (1) AU2010302940B2 (fr)
BR (1) BR112012006965A2 (fr)
CA (1) CA2776217A1 (fr)
CL (1) CL2012000780A1 (fr)
EA (1) EA021024B1 (fr)
IL (1) IL218739A0 (fr)
IN (1) IN2012DN02709A (fr)
MX (1) MX2012003844A (fr)
SG (1) SG179143A1 (fr)
WO (1) WO2011038446A1 (fr)
ZA (1) ZA201201941B (fr)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2910320B1 (fr) 2006-12-21 2009-02-13 Galderma Res & Dev S N C Snc Emulsion comprenant au moins un retinoide et du peroxyde de benzole
FR2910321B1 (fr) 2006-12-21 2009-07-10 Galderma Res & Dev S N C Snc Gel creme comprenant au moins un retinoide et du peroxyde de benzole
JP2013514424A (ja) * 2009-12-18 2013-04-25 コーニンクレッカ フィリップス エレクトロニクス エヌ ヴィ シェービングのためのポリエチレングリコール含有組成物
FR2969493B1 (fr) * 2010-12-23 2013-07-05 Galderma Res & Dev Mousses dermatologiques obtenues a partir d'un gel ou d'une suspension contenant du bpo
US10426761B2 (en) 2011-04-19 2019-10-01 Arms Pharmaceutical, Llc Method for treatment of disease caused or aggravated by microorganisms or relieving symptoms thereof
JP2014518555A (ja) * 2011-04-19 2014-07-31 アームズ ファーマシューティカル エルエルシー 有害な微生物を阻害する方法及びそのためのバリア形成組成物
JP6332902B2 (ja) * 2012-10-29 2018-05-30 株式会社ピカソ美化学研究所 美容用組成物
CN106456655A (zh) * 2014-03-17 2017-02-22 Gfs澳大利亚私人股份有限公司 抗菌消毒组合物及其用途
CN107106491A (zh) * 2014-12-24 2017-08-29 宝丽制药股份有限公司 筛网起泡器用的外用组合物
US9161932B1 (en) 2015-01-15 2015-10-20 Michael Smith Anesthetic and cooling mixture
US10000728B2 (en) 2015-07-17 2018-06-19 S. C. Johnson & Son, Inc. Cleaning composition with propellant
KR102394637B1 (ko) * 2015-09-30 2022-05-09 (주)아모레퍼시픽 에어로졸 제형의 탈모 방지 또는 육모 촉진용 조성물
US10933018B2 (en) 2015-10-30 2021-03-02 Timber Pharmaceuticals Llc Isotretinoin formulations and uses and methods thereof
US10420714B2 (en) 2016-09-30 2019-09-24 L'oreal Foaming cosmetic compositions and methods for producing the same
US10172782B2 (en) 2016-09-30 2019-01-08 L'oreal Compositions and methods for treating hair
US20180092826A1 (en) * 2016-09-30 2018-04-05 L'oreal Compositions and methods for treating hair
DE102016222160A1 (de) 2016-11-11 2018-05-17 Beiersdorf Ag Gesichtsreinigungsprodukt mit besonderer Schaumqualität und Sensorik
CN109512686A (zh) * 2018-12-26 2019-03-26 广州蜜妆生物科技有限公司 一种免洗香波及其制备方法
SI25540A (sl) * 2019-01-14 2019-05-31 Tompa Majcen Dominika Formulacije s spojinami aktivnega kisika in pripomočki za njihovo aplikacijo

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5002680A (en) * 1985-03-01 1991-03-26 The Procter & Gamble Company Mild skin cleansing aerosol mousse with skin feel and moisturization benefits
ATE52185T1 (de) * 1985-03-01 1990-05-15 Procter & Gamble Milder reinigungsschaum.
US4869897A (en) * 1987-10-22 1989-09-26 The Procter & Gamble Company Photoprotection compositions comprising sorbohydroxamic acid
WO1993021899A1 (fr) * 1992-05-05 1993-11-11 The Procter & Gamble Company Composition de traitement de l'acne
IL152486A0 (en) * 2002-10-25 2003-05-29 Meir Eini Alcohol-free cosmetic and pharmaceutical foam carrier
US20060193789A1 (en) * 2002-10-25 2006-08-31 Foamix Ltd. Film forming foamable composition
US7700076B2 (en) * 2002-10-25 2010-04-20 Foamix, Ltd. Penetrating pharmaceutical foam
WO2005094764A1 (fr) * 2004-03-12 2005-10-13 The Gillette Company Produits de gel de rasage
DE102004050239A1 (de) * 2004-10-15 2005-05-12 Clariant Gmbh Kosmetische, pharmazeutische und dermatologische Mittel
EP2108360A3 (fr) * 2005-10-24 2010-06-09 Collegium Pharmaceutical, Inc. Composition de mousse pharmaceutique topique
US20070202061A1 (en) * 2005-10-31 2007-08-30 Naturalnano, Inc. Cosmetic skincare applications employing mineral-derived tubules for controlled release
ES2393761T3 (es) * 2006-07-14 2012-12-27 Stiefel Research Australia Pty Ltd Espuma farmacéutica de ácido graso
ZA200900316B (en) * 2006-07-25 2010-05-26 Alcon Res Ltd Antagonists of endothelial differentiation gene subfamily 3 (EDG-3, S1P3) receptors for prevention and treatment of ocular disorders
US8349296B2 (en) * 2006-12-21 2013-01-08 Kpss-Kao Professional Salon Services Gmbh Aerosol foam composition
US8003594B2 (en) * 2007-04-30 2011-08-23 Kimberly-Clark Worldwide, Inc. Foamable moisturizing compositions
US8652443B2 (en) * 2008-02-14 2014-02-18 Precision Dermatology, Inc. Foamable microemulsion compositions for topical administration

Also Published As

Publication number Publication date
CN102711732B (zh) 2014-08-13
KR20120081109A (ko) 2012-07-18
IL218739A0 (en) 2012-06-28
WO2011038446A8 (fr) 2011-06-09
JP2016029076A (ja) 2016-03-03
CA2776217A1 (fr) 2011-04-07
EP2482800A1 (fr) 2012-08-08
ZA201201941B (en) 2012-11-28
EA021024B1 (ru) 2015-03-31
EP2482800A4 (fr) 2013-10-30
WO2011038446A1 (fr) 2011-04-07
AU2010302940B2 (en) 2013-08-22
CN102711732A (zh) 2012-10-03
SG179143A1 (en) 2012-05-30
US20130108557A1 (en) 2013-05-02
CL2012000780A1 (es) 2012-08-31
MX2012003844A (es) 2012-05-08
EA201270478A1 (ru) 2012-09-28
BR112012006965A2 (pt) 2017-08-29
AU2010302940A1 (en) 2012-04-12
JP2013505967A (ja) 2013-02-21

Similar Documents

Publication Publication Date Title
IN2012DN02709A (fr)
WO2012047857A3 (fr) Couplage d'agents rationnels à des processus quantiques
WO2008021256A3 (fr) Hydroxydes métalliques nanoplaquettaires et leurs méthodes d'élaboration
WO2010149798A3 (fr) Utilisation de polyols pour augmenter l'effet de refroidissement d'une substance refroidissante et mélanges refroidissants ayant un plus grand effet de refroidissement
WO2011061330A3 (fr) Utilisation d'agents rafraîchissants physiologiques et produits contenant de tels agents
WO2010129288A3 (fr) Marqueurs d'évènement comestibles à haute fiabilité et leurs procédés d'utilisation
WO2006047788A3 (fr) Procedes et dispositifs de liberation prolongee in vivo d'un agent actif
WO2010125470A3 (fr) Véhicule moussant et compositions pharmaceutiques comportant des solvants polaires aprotiques et leurs utilisations
WO2011002808A8 (fr) Inhibiteurs de la protéase du vhc et leurs utilisations
WO2011072099A3 (fr) Compositions et procédés comprenant des variants de protéase
WO2010054108A8 (fr) Polypeptides cas6 et procédés d'utilisation
TW200702350A (en) Two-liquid curing type aqueous resin composition and use thereof
FR2964565B1 (fr) Composition cosmetique comprenant un polymere fixant et un agent antipelliculaire
WO2012066537A3 (fr) Compositions pour une administration transdermique de prinicipes actifs
WO2013151576A3 (fr) Échafaudages segmentés et leur mise à disposition pour des applications périphériques
WO2009077500A3 (fr) Azolylméthyloxiranes, leur utilisation et agents les contenant
WO2010014949A3 (fr) Compositions comprenant des cellules hépato-mimétiques et leurs utilisations
WO2011126250A3 (fr) Composition contenant un inhibiteur de pde5 pour l'atténuation des rides de la peau
MX2016000477A (es) Composicion de espuma de poliuretano para paneles discontinuos formados bajo una presion reducida.
WO2012051117A3 (fr) Benzamides substitués et leurs utilisations
WO2008089488A3 (fr) Dispositifs intravaginaux biodégradables pour la délivrance d'agents thérapeutiques
WO2009138801A3 (fr) Formulation cosmétique
WO2010131230A3 (fr) Compositions, systèmes et procédé pour génération d'alcalinité in situ
WO2013092457A3 (fr) Associations de principes actifs à base d'un ou de plusieurs acides carboxyliques, notamment d'acides hydroxycarboxyliques, et d'un ou de plusieurs acides hydroxamiques physiologiquement acceptables, ainsi que préparations cosmétiques ou dermatologiques contenant de telles associations de principes actifs
WO2011127244A3 (fr) Formulations de sulfate d'atazanavir avec un effet ph amélioré